Medicine
Detectnet 1 mCi/mL injection
Detectnet 1 mCi/mL injection is a prescription medicine containing Copper oxodotreotide cu-64 for intravenous use, marketed by Curium, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store Detectnet at controlled room temperature 20 ° C to 25 ° C (68 ° F to 77…
Key facts
- Active ingredient (INN)
- Copper oxodotreotide cu-64
- Brand
- Detectnet
- Strength
- 1 mCi/mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial
- Marketing authorisation holder
- Curium
- Manufacturer
- Curium
- Origin register
- US FDA, United States
- Storage
- Store Detectnet at controlled room temperature 20 ° C to 25 ° C (68 ° F to 77 ° F). Store Detectnet in an upright position within the lead shielding to protect handlers from exposure to radiation. Store and dispose of Detectnet in compliance with the appropriate regulations of the government agency authorized to license the use of this radionuclide.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 September 2020
- Identifiers
- DailyMed set ID f898c8a7-beb7-4318-a8ea-6f058d69342bNDC 69945-064Application NDA213227
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-use in 1 can / 4 mL in 1 vial, single-use | 69945-064-01 | Curium | 14 September 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Copper oxodotreotide cu-64 is a radioactive diagnostic agent indicated with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients. It is available as injection for intravenous use. MedsAcross supplies Copper oxodotreotide cu-64 for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Copper oxodotreotide cu-64For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Detectnet prescribing information (Curium) · U.S. National Library of Medicine, DailyMed
Need Detectnet 1 mCi/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.